These findings are consistent with previous studies (Jin et al., 2015; Zhuang et al., 2020), which found that cognitive impairment or psychiatric disorder frequently constitute the initial clinical symptoms of patients with CSF1R-microglial encephalopathy. This evidence concerns the gene CSF1R and psychiatric disorder.